Technology Development for the Synthesis of S-Amlodipine Nicotinate Drug Substance

被引:0
|
作者
G. A. Kim
Zh. M. Kozlova
S. O. Pchelintsev
R. T. Savel’yanova
N. M. Berezina
I. I. Krasnyuk
机构
[1] Ministry of Public Health of the Russian Federation,All
[2] I. M. Sechenov First Moscow State Medical University,Russia Scientific Center for Safety Testing of Biologically Active Substances
[3] EcoChem-Innovations,undefined
来源
关键词
-amlodipine nicotinate; amlodipine optical isomers; nicotinic acid;
D O I
暂无
中图分类号
学科分类号
摘要
Technology for the synthesis of S-amlodipine nicotinate drug substance was developed based on an acceptable method of effective separation of the amlodipine optical isomers. A literature review suggested that the most promising methods employed 2-propanol (pure or with small additions of cosolvents) as the main solvent. However, experiments showed that the optimum solvent was DMSO. The proposed synthesis of S-amlodipine nicotinate drug substance was confirmed to be stable and reproducible. Standardization methods were developed.
引用
收藏
页码:761 / 763
页数:2
相关论文
共 50 条
  • [1] Technology Development for the Synthesis of S-Amlodipine Nicotinate Drug Substance
    Kim, G. A.
    Kozlova, Zh. M.
    Pchelintsev, S. O.
    Savel'yanova, R. T.
    Berezina, N. M.
    Krasnyuk, I. I.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2017, 50 (11) : 761 - 763
  • [2] Modern views on amlodipine and new S-amlodipine medications
    Leonova, M. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (04): : 117 - 120
  • [3] Contemporary sight at amlodipine and new drugs of S-amlodipine
    Leonova, M. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (02) : 227 - 230
  • [4] S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
    Sang-Ho Jo
    Sung-Ji Park
    Eung Ju Kim
    Soo-Joong Kim
    Hyun-Jae Cho
    Jong-Min Song
    Jinho Shin
    Jin Joo Park
    Joon-Han Shin
    Kyoo-Rok Han
    Dong-Ju Choi
    Trials, 19
  • [5] S-Amlodipine: An Isomer with Difference-Time to Shift from Racemic Amlodipine
    Dalal, Jamshed
    Mohan, J. C.
    Iyengar, S. S.
    Hiremath, Jagdish
    Sathyamurthy, Immaneni
    Bansal, Sandeep
    Kahali, Dhiman
    Dasbiswas, Arup
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2018, 2018
  • [6] S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
    Jo, Sang-Ho
    Park, Sung-Ji
    Kim, Eung Ju
    Kim, Soo-Joong
    Cho, Hyun-Jae
    Song, Jong-Min
    Shin, Jinho
    Park, Jin Joo
    Shin, Joon-Han
    Han, Kyoo-Rok
    Choi, Dong-Ju
    TRIALS, 2018, 19
  • [7] A drug-in-adhesive transdermal patch for S-amlodipine free base: In vitro and in vivo characterization
    Sun, Yinghua
    Fang, Liang
    Zhu, Meng
    Li, Wei
    Meng, Ping
    Li, Li
    He, Zhonggui
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 382 (1-2) : 165 - 171
  • [8] A RETROSPECTIVE COST-EFFECTIVENESS ANALYSIS OF S-AMLODIPINE IN CHINA
    Hu, S. L.
    Zhang, Y.
    He, J.
    Du, L.
    VALUE IN HEALTH, 2014, 17 (07) : A758 - A758
  • [9] Peripheral Oedema due to S-Amlodipine - A Report of Three Cases
    Paudel, R.
    Palaian, S.
    Kishore, P., V
    Shankar, Ravi P.
    Mishra, P.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2007, 1 (06) : 533 - 536
  • [10] Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects
    Oh, Mi Jin
    Hwang, Hyun Hwan
    Kim, Hyun Gyu
    Lee, Geun Hyeog
    Cho, Yun-Seok
    Lee, Sun Young
    Kang, Soo Yeon
    Cho, Kyung Hee
    Lee, Yun Young
    Lee, Yun Jeong
    Jang, Choon-Gon
    Lee, Seok-Yong
    CLINICAL THERAPEUTICS, 2017, 39 (07) : 1371 - 1379